跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Xolair 150mg Powder and Solvent for Solution for Injection - HSA Drug Approval Details
Approvals
/
HSA
/
Xolair 150mg Powder and Solvent for Solution for Injection
Approved
STANDARD
Xolair 150mg Powder and Solvent for Solution for Injection
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
dc0f0d411be3fd54
Company
Unknown
Type
Standard
Approval Details
Approval Id
dc0f0d411be3fd54
Drug Name
Xolair 150mg Powder and Solvent for Solution for Injection
Active Ingredients
Omalizumab
150mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
dc0f0d411be3fd54
Type
Standard
Back to HSA Approvals